Robert C. Bast Jr.
Robert Clinton Bast Jr., (born December 8, 1943) is an American physician-scientist who is currently Vice President for Translational Research at the University of Texas M.D. Anderson Cancer Center. Bast is best known for the discovery of CA125, a serum biomarker for ovarian cancer that has contributed to the care of ovarian cancer patients worldwide. His research spans early detection, enhancing chemotherapy and understanding regulation of dormancy and the role of autophagy in breast and ovarian cancer.
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
Robert C. Bast Jr.
Robert Clinton Bast Jr., (born December 8, 1943) is an American physician-scientist who is currently Vice President for Translational Research at the University of Texas M.D. Anderson Cancer Center. Bast is best known for the discovery of CA125, a serum biomarker for ovarian cancer that has contributed to the care of ovarian cancer patients worldwide. His research spans early detection, enhancing chemotherapy and understanding regulation of dormancy and the role of autophagy in breast and ovarian cancer.
has abstract
Robert Clinton Bast Jr., (born ...... in breast and ovarian cancer.
@en
birth date
1943-12-08
institution
Link from a Wikipage to an external page
Wikipage page ID
60,831,539
page length (characters) of wiki page
Wikipage revision ID
917,360,824
Link from a Wikipage to another Wikipage
alma mater
@en
Harvard Medical School
@en
Wesleyan University
@en
birth date
1943-12-08
name
Robert C. Bast Jr.
@en
website
@en
wikiPageUsesTemplate
workplaces
subject
comment
Robert Clinton Bast Jr., (born ...... in breast and ovarian cancer.
@en
label
Robert C. Bast Jr.
@en
sameAs
wasDerivedFrom
homepage
isPrimaryTopicOf
name
Robert C. Bast Jr.
@en